Skip to main navigation Skip to search Skip to main content

Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli

  • Stanford University

Research output: Contribution to journalArticlepeer-review

721 Scopus citations

Abstract

The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.

Original languageEnglish
Pages (from-to)1790-1792
Number of pages3
JournalScience
Volume291
Issue number5509
DOIs
StatePublished - Mar 2 2001

Fingerprint

Dive into the research topics of 'Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli'. Together they form a unique fingerprint.

Cite this